This Is What Whales Are Betting On Eli Lilly and Co
This Is What Whales Are Betting On Eli Lilly and Co
Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co.
有很多錢可花費的鯨魚已經明顯看漲禮來。
Looking at options history for Eli Lilly and Co (NYSE:LLY) we detected 12 trades.
查看禮來 (紐交所:LLY) 期權歷史記錄，我們檢測到12筆交易。
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 25% with bearish.
如果我們考慮每次交易的具體情況，可以準確地說，58%的投資者看漲，25%看淡。
From the overall spotted trades, 4 are puts, for a total amount of $150,700 and 8, calls, for a total amount of $372,495.
從所有檢測到的交易中，有4筆爲看跌期權，總金額爲150,700美元，有8筆爲看漲期權，總金額爲372,495美元。
What's The Price Target?
價格目標是什麼？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $380.0 and $1000.0 for Eli Lilly and Co, spanning the last three months.
在評估交易量和未平倉合約後，顯然主要市場動力已經關注 禮來 的價格區間在380.0至1000.0美元之間，涵蓋了過去三個月。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly and Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly and Co's substantial trades, within a strike price spectrum from $380.0 to $1000.0 over the preceding 30 days.
評估成交量和未平倉合約是期權交易的戰略步驟。這些指標揭示了投資者針對特定行權價格禮來的期權的流動性和投資者興趣。下面的數據可視化了過去30天內涵蓋380.0至1000.0美元行權價格區間內與 禮來 大量交易相關的看跌期權和看漲期權的成交量和未平倉合約的波動。
Eli Lilly and Co Option Activity Analysis: Last 30 Days
禮來 期權活動分析：過去30天
Biggest Options Spotted:
最大的期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BULLISH | 08/16/24 | $51.2 | $49.75 | $50.7 | $880.00 | $101.4K | 274 | 10 |
| LLY | CALL | TRADE | BULLISH | 01/17/25 | $524.9 | $520.35 | $524.9 | $380.00 | $52.4K | 65 | 0 |
| LLY | CALL | TRADE | BULLISH | 03/21/25 | $104.95 | $101.35 | $104.95 | $900.00 | $52.4K | 51 | 0 |
| LLY | CALL | TRADE | NEUTRAL | 08/16/24 | $53.45 | $49.7 | $51.6 | $880.00 | $51.6K | 274 | 0 |
| LLY | PUT | TRADE | BEARISH | 01/17/25 | $53.0 | $51.6 | $53.0 | $860.00 | $42.4K | 43 | 8 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 交易 | 看好 | 08/16/24 | $51.2 | $49.75 | $50.7 | $880.00 | $101.4K | 274 | 10 |
| LLY | 看漲 | 交易 | 看好 | 01/17/25 | $524.9 | $520.35 | $524.9 | $380.00 | $52.4千美元 | 65 | 0 |
| LLY | 看漲 | 交易 | 看好 | 03/21/25 | $104.95 | $101.35 | $104.95 | $900.00 | $52.4千美元 | 51 | 0 |
| LLY | 看漲 | 交易 | 中立 | 08/16/24 | $53.45 | $49.7 | $51.6 | $880.00 | $51.6K | 274 | 0 |
| LLY | 看跌 | 交易 | 看淡 | 01/17/25 | $53.0 | $51.6 | $53.0 | $860.00 | $42.4K | 43 | 8 |
About Eli Lilly and Co
關於禮來
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
禮來是一家專注於神經科學、心臟代謝、癌症和免疫學的製藥公司。禮來的主要產品包括用於癌症的維津尼奧；馬天尼羅、澤普邦、賈達信、特魯利康、胰島素諾和人用胰島素用於糖尿病；以及用於免疫學的塔吉特和優泰樂。
Following our analysis of the options activities associated with Eli Lilly and Co, we pivot to a closer look at the company's own performance.
在分析了禮來期權交易活動之後，我們轉而更近距離地觀察公司自身的業績。
Where Is Eli Lilly and Co Standing Right Now?
禮來現在處於什麼位置?
- Trading volume stands at 43,681, with LLY's price down by 0.0%, positioned at $890.11.
- RSI indicators show the stock to be may be overbought.
- Earnings announcement expected in 42 days.
- 成交量爲43,681手，LLY的價格下跌0.0%，位於890.11美元。
- RSI指示股票可能已超買。
- 預計在42天內公佈收益報告。
What The Experts Say On Eli Lilly and Co
關於禮來股份的專家說法
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $948.4.
過去一個月中，有5位行業分析師分享了他們對這支股票的見解，提出了平均目標價爲948.4美元。
- Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Eli Lilly and Co, targeting a price of $957.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Eli Lilly and Co with a target price of $1000.
- An analyst from Jefferies has decided to maintain their Buy rating on Eli Lilly and Co, which currently sits at a price target of $1015.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- Jefferies的一位分析師繼續持有禮來的買入評級，並將目標價設定爲957美元。
- Cantor Fitzgerald的一位分析師將其評級下調爲超配，目標價爲885美元。
- B of A Securities的一位分析師在評估後仍然對禮來持有買入評級，並對禮來設定1000美元的目標價。
- Jefferies的一位分析師決定維持對 禮來 的買入評級，其當前的目標價爲1015美元。
- Cantor Fitzgerald的一位分析師將其評級下調爲超配，目標價爲885美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly and Co options trades with real-time alerts from Benzinga Pro.
期權交易帶來更高的風險和潛在回報。精明的交易者通過持續教育自己、調整策略、監控多個因子、密切關注市場動態來管理這些風險。通過Benzinga Pro全天實時提醒了解最新的禮來期權交易。
譯文內容由第三人軟體翻譯。